Article
Sanofi's Dupixent wins U.S. approval for bigger use
Rating:
0.0
Views:
59
Likes:
1
Library:
1
Sanofi won expanded U.S. approval for its best-selling Dupixent injection to treat an allergic inflammation of the esophagus, the Food and Drug Administration said on Friday.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value